Category: NASDAQPCVX
-
Vaxcyte stock on data for pneumococcal shot (NASDAQ:PCVX)
•
Kittisak Kaewchalon/iStock via Getty Images Vaccine cellNASDAQ:PCVX) stocks Added ~32% Pfizer announced Tuesday that it will market its experimental VAX-31 pneumococcal vaccine (PCV) after it showed a similar safety profile to Pfizer’s (NYSE:PFE) A competitor shot Prevnar 20 in a Phase 1/2 trial. Based on preliminary data from the study,…